Review
Clinical features and diagnostic progress of activated phosphoinositide 3-kinase δ syndrome
Yang Boke, Wu Tao, An Yaqin, Bai Hai
Published 2022-07-01
Cite as Clin Med Chin, 2022, 38(4): 373-377. DOI: 10.3760/cma.j.cn101721-20210907-000124
Abstract
Activated phosphoinositide 3-kinase δ syndrome(APDS) is an autosomal dominant inherited primary immunodeficiency disease that is caused by mutations in PIK3CD or PIK3R1 genes leading to overactivation of the PI3Kδ signaling pathway, first reported by Angulo et al in 2013. The clinical manifestations of the disease are recurrent respiratory tract infections, benign lymph node hyperplasia, autoimmune diseases, lymphoma and so on. Although most patients develop the disease in childhood, there are also reports of adult onset and asymptomatic patients. In addition, the immunophenotype of activated phosphoinositide 3-kinase δ syndrome is changeable, usually the IgA levels are reduced, the IgM levels can be normal or elevated, and the IgG levels are variable, so it is easy to be misdiagnosed at first diagnosis. There is no unified diagnostic standard at present, and timely genetic testing is required to confirm the diagnosis.
Key words:
Activated phosphoinositide 3-kinase δ syndrome; Signal pathway; Primary immunodeficiency disease; Lymphadenopathy
Contributor Information
Yang Boke
Blood Disease Center of All Army, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, China
Wu Tao
Blood Disease Center of All Army, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, China
An Yaqin
Blood Disease Center of All Army, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, China
Bai Hai
Blood Disease Center of All Army, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, China